These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7330795)

  • 21. Minocycline, doxycycline and tetracycline levels in serum and bronchial secretions of patients with chronic bronchitis.
    Ruhen RW; Tandon MK
    Pathology; 1975 Jul; 7(3):193-7. PubMed ID: 1196678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sputum antimicrobial levels and clinical outcome in bronchitis.
    Hitt JA; Gerding DN
    Semin Respir Infect; 1991 Jun; 6(2):122-8. PubMed ID: 1771303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Respiratory tract penetration of quinolone antimicrobials: a case in study.
    Ritrovato CA; Deeter RG
    Pharmacotherapy; 1991; 11(1):38-49. PubMed ID: 2020610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacokinetics of cefotaxime and desacetylcefotaxime in the blood serum and bronchial secretion in patients with chronic bronchitis after administration of a single 24-hour dose].
    Kamnev IuV; Manuĭlov KK; Orlov VA; Sokolova VI
    Antibiot Khimioter; 1991 Oct; 36(10):42-4. PubMed ID: 1805696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. De novo generation of histamine in sputum and the effect of antibiotics.
    Sheinman BD; Devalia JL; Crook SJ; Davies RJ
    Agents Actions; 1986 Mar; 17(5-6):449-53. PubMed ID: 3706048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Penetration of piperacillin into bronchial mucosa and sputum.
    Marlin GE; Burgess KR; Burgoyne J; Funnell GR; Guinness MD
    Thorax; 1981 Oct; 36(10):774-80. PubMed ID: 6460337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of cellular and molecular biomarkers to manage COPD exacerbations.
    Ho T; Dasgupta A; Hargreave FE; Nair P
    Expert Rev Respir Med; 2017 May; 11(5):403-411. PubMed ID: 28347199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative immunoelectrophoretic analysis of the plasma proteins in the sol phase of sputum from patients with chronic bronchitis.
    Ryley HC; Brogan TD
    J Clin Pathol; 1973 Nov; 26(11):852-6. PubMed ID: 4128930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cefoperazone pharmacokinetics and sputum levels after single/multiple i.m. injections in bronchopneumopathic patients and bone, pulmonary and prostatic tissue penetration.
    Braga PC; Scaglione F; Villa S; Scarpazza G; Gagliardi V; Biella G; Manganelli V; Paiola G; Fraschini F
    Int J Clin Pharmacol Res; 1983; 3(5):349-55. PubMed ID: 6678828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Beeh KM; Beier J; Candler H; Wittig T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Twice daily dosage of bacampicillin in chronic bronchitis. A double-blind study.
    Davies BI; Maesen FP; Brombacher PJ; Sjövall J
    Scand J Respir Dis; 1978 Oct; 59(5):249-56. PubMed ID: 32615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serum and sputum levels of cefotetan used in respiratory tract infections].
    Matsumoto Y; Hitsuda Y; Sugimoto Y; Ishikawa J; Sasaki T
    Jpn J Antibiot; 1986 Oct; 39(10):2690-4. PubMed ID: 3468274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters.
    Thompson AB; Daughton D; Robbins RA; Ghafouri MA; Oehlerking M; Rennard SI
    Am Rev Respir Dis; 1989 Dec; 140(6):1527-37. PubMed ID: 2604284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Airway eosinophilia in chronic bronchitis during exacerbations.
    Saetta M; Di Stefano A; Maestrelli P; Turato G; Ruggieri MP; Roggeri A; Calcagni P; Mapp CE; Ciaccia A; Fabbri LM
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1646-52. PubMed ID: 7952628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The level of biogenic amines in bronchi of patients with chronic obstructive bronchitis].
    Malakauskas KK; Goncharova VA; Aleksandrova NI
    Klin Med (Mosk); 1991 May; 69(5):60-3. PubMed ID: 1857081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacodynamics of levofloxacin in patients with acute exacerbation of chronic bronchitis.
    Cazzola M; Matera MG; Donnarumma G; Tufano MA; Sanduzzi A; Marchetti F; Blasi F
    Chest; 2005 Oct; 128(4):2093-8. PubMed ID: 16236860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concentrations of ceftibuten in bronchial secretions.
    Scaglione F; Triscari F; Demartini G; Arcidiacono M; Cocuzza C; Fraschini F
    Chemotherapy; 1995; 41(4):229-33. PubMed ID: 7555201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of bromhexine on levels of netilmicin in serum, saliva, bronchial secretions and bronchial tissue in patients with chronic obstructive pneumopathy].
    Bariffi F; De Marino V; Pisanti N; Sanduzzi A; Giacomelli P; Vatrella A; Gentile A; Capone D
    G Ital Chemioter; 1986; 33(1):67-70. PubMed ID: 3817381
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of adhesion of Haemophilus influenzae to buccal cells by respiratory secretions.
    Taylor DC; Cripps AW; Clancy RL
    Immunol Cell Biol; 1990 Oct; 68 ( Pt 5)():335-42. PubMed ID: 2083954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple-dose pharmacokinetics in serum and sputum of sagamicin administered intramuscularly to patients.
    Fraschini F; Scaglione F; Scarpazza G; Marchi M; Braga PC
    Chemotherapy; 1987; 33(2):85-92. PubMed ID: 3568801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.